Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Merck & Co., Inc. (MRK) had Stock-Based Compensation of $761.00M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$15.62B |
|
$3.74B |
|
$3.83B |
|
$11.80B |
|
$11.28B |
|
$4.35B |
|
$-179.00M |
|
$4.17B |
|
$4.22B |
|
$3.74B |
|
$3.74B |
|
$3.74B |
|
$3.80B |
|
$4.35B |
|
$5.55B |
|
2.53B |
|
2.54B |
|
$1.48 |
|
$1.49 |
|
| Balance Sheet Financials | |
$38.78B |
|
$23.78B |
|
$78.32B |
|
$117.11B |
|
$28.42B |
|
$34.46B |
|
$42.31B |
|
$70.73B |
|
$46.37B |
|
$8.33B |
|
$46.37B |
|
2.53B |
|
| Cash Flow Statement Financials | |
$21.47B |
|
$-7.73B |
|
$-7.03B |
|
$6.91B |
|
$13.32B |
|
$6.41B |
|
|
Stock-Based Compensation |
$761.00M |
$-7.84B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.36 |
|
-- |
|
-- |
|
0.43 |
|
0.80 |
|
75.50% |
|
27.84% |
|
27.84% |
|
-- |
|
26.69% |
|
23.96% |
|
$18.10B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.63 |
|
1.52 |
|
59.21 |
|
8.07% |
|
44.92% |
|
3.20% |
|
4.63% |
|
$18.35 |
|
$7.12 |
|
$8.45 |
|